Kappa Bioscience AS Revenue and Competitors
Estimated Revenue & Valuation
- Kappa Bioscience AS's estimated annual revenue is currently $11.3M per year.
- Kappa Bioscience AS's estimated revenue per employee is $217,596
Employee Data
- Kappa Bioscience AS has 52 Employees.
- Kappa Bioscience AS grew their employee count by -13% last year.
Kappa Bioscience AS Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $16.4M | 106 | 29% | N/A | N/A |
#2 | $2M | 9 | -18% | N/A | N/A |
#3 | $3.4M | 20 | 5% | N/A | N/A |
#4 | $3.1M | 20 | -66% | N/A | N/A |
#5 | $4.3M | 29 | 12% | N/A | N/A |
#6 | $7M | 45 | 2% | N/A | N/A |
#7 | $11.3M | 52 | -13% | N/A | N/A |
#8 | N/A | 45 | 29% | N/A | N/A |
What Is Kappa Bioscience AS?
Kappa Bioscience is the pioneer in development and production of the only synthetic and biologically active all-trans menaquinone-7 (vitamin K2 MK-7), marketed under the K2VITAL® brand name. Kappa's innovation of MK-7 synthesis marks the commercial milestone where this fat-soluble vitamin can begin to attain widespread consumer adoption. Effective synthesis production drives scalability, price reduction and a secure supply chain - with unmatched ingredient purity and documentation. Combined with other Kappa innovations such as the patented DELTA® microencapsulation process, which provides K2 stability in mineral formulations, K2VITAL® offers brands and manufacturers a path to broader market segments. Kappa Ingredients GmbH, a wholly owned division of Kappa Bioscience, manages global sales of the K2VITAL® and other product lines directly and through a network of global distributors. Kappa Ingredients GmbH, a wholly owned division of Kappa Bioscience, manages global sales of the K2VITAL® and other product lines - Ingredients and services related to Bones, Joints and Cardiovascular Health - directly and through a network of global distributors. Main products are Vitamin K2 - K2VITAL®, Calcified Atlantic Seaweed®, The Bone Health Triangle®.
keywords:N/AN/A
Total Funding
52
Number of Employees
$11.3M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kappa Bioscience AS's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Global Distributors Management | Reveal Email/Phone |
3 | EVP QA & RA | Reveal Email/Phone |
4 | Manager Administration, Organization & HSE | Reveal Email/Phone |
5 | Marketing & Business Development Manager | Reveal Email/Phone |
6 | Director Business Development APAC | Reveal Email/Phone |
7 | Sales Manager | Reveal Email/Phone |
8 | Director Finance & Administration / Prokuristin | Reveal Email/Phone |
9 | Exhibition and Event Manager | Reveal Email/Phone |
10 | Senior Sales Manager | Reveal Email/Phone |
Kappa Bioscience AS News
Kappa Bioscience [Norway] , NattoPharma [Norway], Gnosis [Italy], DSM [Netherlands] , Viridis BioPharma [India] , Frutarom [Israel] , DuPont...
The study provides a detailed profile of key players which include: Kappa Bioscience; NattoPharma; Gnosis; Guandong Sungen; Viridis BioPharma...
Kappa Bioscience (Oslo, Norway) appointed Rena Cohen-First as vice president of sales North America. Previously, Cohen-First was vice...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.7M | 52 | -7% | N/A |
#2 | $5.5M | 52 | 6% | N/A |
#3 | $13.3M | 52 | -12% | N/A |
#4 | N/A | 52 | 21% | N/A |
#5 | $6.8M | 52 | 4% | N/A |